Skip to main content
Log in

Discovery of a novel serine protease inhibitor utilizing a structure-based and experimental selection of fragments technique

  • Published:
Journal of Computer-Aided Molecular Design Aims and scope Submit manuscript

Abstract

We report a set of strategies to develop novel ligands (Structure Based and Experimental Selection of Fragments: SbE-SF). First, a docking simulation utilizing DOCK3.5 is performed in order to screen the fragment database, which was generated with the in-house program FRAGMENT++ specifically for docking simulation purposes. Although the affinity of these small molecules (fragments) is expected to be low, the affinity of fragments selected by computation is assayed by experiment to determine which ones can be potent inhibitors. After determining such key fragments, additional fragments are attached to the key ones in order to increase the binding affinity,taking into account the binding modes predicted by computation. This method has been applied to a thrombin inhibitor study, resulting in the discovery of a novel inhibitor exhibiting pIC50 = 7.9.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Mizutani, M.Y., Tomioka, N. and Itai, A., J. Mol. Biol., 243 (1994) 310.

    Google Scholar 

  2. Rarey, M., Kramer, B., Lengauer, T., Klebe and G., J. Mol. Biol., 261 (1996) 470.

    Google Scholar 

  3. Welch, W., Ruppert, J. and Jain, A., Chem. & Biol., 3 (1996) 449.

    Google Scholar 

  4. Makino, S. and Kuntz, I.D., J. Comp. Chem., 18 (1997) 1812.

    Google Scholar 

  5. Available Chemical Directory (ACD) available from Center for Scientific Computing (CSC), Tekniikantie 15 a D,Otaniemi, Espoo, Finland.

  6. e.g. Available Chemical Directory (ACD), MDL Drug Data Report (MDDR), National Cancer Institute (NCI) are available from Center for Scientific Computing (CSC), Tekniikantie 15 a D,Otaniemi, Espoo, Finland.

  7. Nishibata, Y. and Itai, A., J. Med. Chem., 36 (1989) 2921.

    Google Scholar 

  8. Moon, J.B. and Howe, W.J., Proteins, 11, (1991) 314.

    Google Scholar 

  9. Roe, D.C. and Kuntz, I.D., J. Comp. Aid. Mol. Des., 9 (1995) 269.

    Google Scholar 

  10. Böhm, H.-J., J. Comp. Aid. Mol. Des., 10 (1996) 265.

    Google Scholar 

  11. Kick, E.K., Roe, D.C., Skillman, A.G., Liu, G.C., Ewing, T.J.A., Sun, Y., Kuntz, I.D. and Ellman, J.A., Chem. Biol., 4 (1997) 297.

    Google Scholar 

  12. Shuker, S.B., Hajduk, P.J., Meadows, R.P. and Fesik, S.W., Science, 274, (1996) 1531.

    Google Scholar 

  13. Fejzo, J., Lepre, C.A., Peng, J.W., Bemis, G.W., Ajay, Murcko, M.A. and Moore, J.M., Chem. Biol., 6 (1999) 755.

    Google Scholar 

  14. SYBYL, Version 6.0.2, Tripos Associates, St. Louis, MO, 1993.

  15. SYBYL Programming Language (SPL), Tripos Associates, St. Louis, MO, 1993.

  16. Available from ftp://ftp.gnu.org/pub/gnu/gcc.

  17. Kaiser, B., Drugs Future, 23 (1998) 423.

    Google Scholar 

  18. Protein Data Bank, Chemistry Department, Building 555, Brookhaven National Laboratory, Upton, NY 11973.

  19. Dyke, S. F. and Kinsman, R. G., in Weissberger, A. and Yaylor, E.C. (eds), The Chemistry of Heterocyclic Compounds, Vol.

  20. 38 John Wiley & Sons, New York, NY, 1981; p. 8.

  21. Sturzebecher, J., Vieweg, H., Wikstrom, P., Turk, D., and Bode, W., BiolChem. Hoppe-Seyler, 373 (1992) 491.

    Google Scholar 

  22. Because this program is still under active development, interested readers should contact the authors concerning its availability.

  23. SLN Manual, Tripos Associates, St. Louis, MO, 1993.

  24. SYBYL, Version 6.02, Tripos Associates, St. Louis, MO, 1993.

  25. Gasteiger, J. and Marsili, M., Tetrahedron, 36 (1980) 3210.

    Google Scholar 

  26. Banner, D.W. and Hadvary, P., J. Biol. Chem., 266 (1991) 20085.

    Google Scholar 

  27. Docking simulations with various charge models were performed without finding significant difference in the results.

  28. SYBYL Command Manual, Tailor:MAXIMIN2, Tripos Associates, St. Louis, MO, 1993.

  29. DOCK3.5 manual, Edited by D. A. Gschwend, Department of Pharmaceutical Chemistry, University of California, San Francisco.

  30. DOCK3.5 manual, p. 13.

  31. Hara, T., Yokoyama, A., Ishihara, H., Yokoyama, Y., Nagahara, T. and Iwamoto, M., Thrombosis Haemostasis, 71 (1994) 314.

    Google Scholar 

  32. Brandstetter, H., Kuhne, A., Bode, W., Huber, R., Saar, W.V.D., Wirthernsohn, K. and Engh, R.A., J. Biol. Chem., 271 (1996) 29988.

    Google Scholar 

  33. Although affinities of several fragments for thrombin were determined experimentally, the affinity of all the fragments other than benzamidine were not determined for FXa (pIC50 < 2.0).

  34. Makino, S., Ewing, T.J.A. and Kuntz, I.D., J. Comp. Aid. Mol. Des., 13 (1999) 513.

    Google Scholar 

  35. CAESA by Peter Johnson, http:// www.chem.leeds.ac.uk/ICAMS/new_web/CAESA/ caesa.htm.

  36. Nakagawa, T., Makino, S., Sagi, K., Takayanagi, M. and Kayahara, T., New Inhibitors of FXa, Patent WO99-47503.

  37. Nakagawa, T, Makino, S., Sagi, K., Takayanagi, M., Yamanashi, M., Yoshida, K., Yukuda, Y., Ishikawa, K., Kayahara, T., Takehana, S., Takahashi, M., Tsuji, T. and Shoji, M., J. Med. Chem. (submitted).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Makino, S., Kayahara, T., Tashiro, K. et al. Discovery of a novel serine protease inhibitor utilizing a structure-based and experimental selection of fragments technique. J Comput Aided Mol Des 15, 553–559 (2001). https://doi.org/10.1023/A:1011196407163

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011196407163

Navigation